Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Final published version, 652 KB, PDF document
The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
Original language | English |
---|---|
Journal | Cephalalgia |
Volume | 41 |
Issue number | 3 |
Pages (from-to) | 279-293 |
Number of pages | 15 |
ISSN | 0333-1024 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Publisher Copyright:
© International Headache Society 2021.
- acute therapy, Health technology assessment (HTA), International Headache Society (IHS), migraine, position statement, preventive treatment
Research areas
ID: 279631357